tiprankstipranks
Trending News
More News >
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
US Market

Supernus Pharmaceuticals (SUPN) Ratios

Compare
536 Followers

Supernus Pharmaceuticals Ratios

SUPN's free cash flow for Q4 2025 was $0.89. For the 2025 fiscal year, SUPN's free cash flow was decreased by $ and operating cash flow was
gt;-0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.90 1.90 2.35 1.70 1.07
Quick Ratio
1.66 1.66 2.16 1.43 0.93
Cash Ratio
0.38 0.38 0.24 0.26 0.14
Solvency Ratio
<0.01 <0.01 0.46 0.24 0.18
Operating Cash Flow Ratio
<0.01 <0.01 0.59 0.38 0.17
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.29
Net Current Asset Value
$ 253.25B$ 253.25B$ 353.73M$ 136.96M$ -82.15M
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.02 0.03 0.03 0.26
Debt-to-Equity Ratio
0.03 0.03 0.03 0.05 0.50
Debt-to-Capital Ratio
0.03 0.03 0.03 0.04 0.33
Long-Term Debt-to-Capital Ratio
0.03 0.03 0.00 0.00 0.00
Financial Leverage Ratio
1.37 1.37 1.32 1.39 1.92
Debt Service Coverage Ratio
0.00 0.00 0.00 36.68 0.37
Interest Coverage Ratio
0.00 0.00 0.00 -2.18 6.52
Debt to Market Cap
10.38 10.82 0.00 0.00 0.21
Interest Debt Per Share
529.52 537.90 0.62 0.81 8.42
Net Debt to EBITDA
-934.56 -2.39K -0.20 -0.37 2.29
Profitability Margins
Gross Profit Margin
85.54%89.63%88.23%86.21%86.93%
EBIT Margin
-7.00%-6.82%14.79%0.85%10.16%
EBITDA Margin
14.60%5.70%26.94%14.82%22.98%
Operating Profit Margin
-6.19%-5.13%12.34%-0.87%6.91%
Pretax Profit Margin
-6.82%-6.82%14.79%0.46%9.10%
Net Profit Margin
-5.36%-5.36%11.16%0.22%9.10%
Continuous Operations Profit Margin
-5.36%-5.36%11.16%0.22%9.10%
Net Income Per EBT
78.63%78.63%75.47%47.53%99.95%
EBT Per EBIT
110.12%133.00%119.84%-52.55%131.69%
Return on Assets (ROA)
>-0.01%>-0.01%5.40%0.10%3.57%
Return on Equity (ROE)
-0.01%>-0.01%7.13%0.14%6.85%
Return on Capital Employed (ROCE)
>-0.01%>-0.01%7.59%-0.53%4.55%
Return on Invested Capital (ROIC)
>-0.01%>-0.01%5.69%-0.25%3.24%
Return on Tangible Assets
>-0.01%>-0.01%10.13%0.23%6.88%
Earnings Yield
-1.32%-1.37%3.71%0.08%3.17%
Efficiency Ratios
Receivables Turnover
<0.01 <0.01 4.66 4.21 4.03
Payables Turnover
0.96 0.69 16.98 42.66 8.27
Inventory Turnover
<0.01 <0.01 1.43 1.08 0.95
Fixed Asset Turnover
0.07 0.07 57.32 44.90 43.98
Asset Turnover
<0.01 <0.01 0.48 0.48 0.39
Working Capital Turnover Ratio
<0.01 <0.01 2.22 4.88 4.01
Cash Conversion Cycle
384.31K 498.11K 311.24 415.30 429.49
Days of Sales Outstanding
95.34K 95.34K 78.36 86.61 90.53
Days of Inventory Outstanding
289.34K 403.30K 254.37 337.24 383.08
Days of Payables Outstanding
378.60 527.71 21.49 8.56 44.12
Operating Cycle
384.68K 498.64K 332.73 423.85 473.61
Cash Flow Ratios
Operating Cash Flow Per Share
0.83 0.84 3.12 2.04 2.18
Free Cash Flow Per Share
0.80 0.81 3.11 2.03 2.17
CapEx Per Share
0.02 0.02 0.01 0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.97 0.97 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
35.37 35.37 237.17 201.61 283.56
Capital Expenditure Coverage Ratio
35.37 35.37 237.17 201.61 283.56
Operating Cash Flow Coverage Ratio
<0.01 <0.01 5.02 2.68 0.26
Operating Cash Flow to Sales Ratio
0.07 0.07 0.26 0.18 0.18
Free Cash Flow Yield
1.57%1.64%8.59%7.00%6.08%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-75.60 -72.78 26.97 1.20K 31.53
Price-to-Sales (P/S) Ratio
4.07 3.90 3.01 2.60 2.87
Price-to-Book (P/B) Ratio
<0.01 <0.01 1.92 1.71 2.16
Price-to-Free Cash Flow (P/FCF) Ratio
63.62 61.00 11.64 14.28 16.44
Price-to-Operating Cash Flow Ratio
61.57 59.28 11.59 14.21 16.39
Price-to-Earnings Growth (PEG) Ratio
0.71 0.48 <0.01 -12.25 2.65
Price-to-Fair Value
<0.01 <0.01 1.92 1.71 2.16
Enterprise Value Multiple
-906.68 -2.32K 10.98 17.16 14.78
Enterprise Value
-95.16B -95.28B 1.96B 1.54B 2.27B
EV to EBITDA
-906.68 -2.32K 10.98 17.16 14.78
EV to Sales
-132.35 -132.52 2.96 2.54 3.40
EV to Free Cash Flow
-2.07K -2.07K 11.43 13.98 19.46
EV to Operating Cash Flow
-2.01K -2.01K 11.38 13.91 19.40
Tangible Book Value Per Share
6.41K 6.51K 7.20 3.75 1.24
Shareholders’ Equity Per Share
18.51K 18.81K 18.80 16.90 16.51
Tax and Other Ratios
Effective Tax Rate
0.21 0.21 0.25 0.52 <0.01
Revenue Per Share
12.54 12.74 12.01 11.14 12.43
Net Income Per Share
-0.67 -0.68 1.34 0.02 1.13
Tax Burden
0.79 0.79 0.75 0.48 1.00
Interest Burden
0.97 1.00 1.00 0.53 0.90
Research & Development to Revenue
0.15 0.15 0.16 0.15 0.11
SG&A to Revenue
0.08 0.00 0.37 0.39 0.16
Stock-Based Compensation to Revenue
0.08 0.05 0.04 0.04 0.03
Income Quality
-0.65 -1.23 2.33 84.41 1.92
Currency in USD